Amgen Inc.
170.683.01 (1.80%)

After hours: 169.55-1.13 (-0.66%) as of 5:27 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close167.67
Bid169.72 x 100
Ask170.00 x 200
52wk Range130.09 - 181.81
Day's Range167.44 - 171.08
Avg Vol (3m)2,837,088
As of 4:00 PM EDT. Market closed.
  • Reuters8 minutes ago

    Amgen again raises 2016 forecast in display of confidence

    Amgen Inc on Wednesday reported higher-than-expected second-quarter profit on increased sales of its blockbuster rheumatoid arthritis drug Enbrel and newer medicines, and the company again raised its full-year forecast. The company is on track to meet or exceed its long-term objectives, Chief Executive Robert Bradway said in a statement. Amgen said it now expects 2016 adjusted earnings per share of $11.10 to $11.40, up from its prior view of $10.85 to $11.20.

  • Investor's Business Daily59 minutes ago

    Amgen Beats Q2 Earnings Estimates, Raises Guidance

    Amgen, the largest biotech by market cap, beat analysts' Q2 estimates and raised its guidance late Wednesday.